[1] |
Listonkova S, Liu S, Bartholomew S, et al. Temporal trends in maternal mortality in Canada II: Estimates based on hospitalization data. J Obstet Gynaecol Can, 2011,33(10):1020-1030.
|
[2] |
World Health Organization. Beyond the numbers: Reviewing maternal deaths and disabilities to make pregnancy safer. Geneva: World Health Organization, 2004.
|
[3] |
Bastkett TF. Epidemiology of obstetric critical care. Best Pract Res Clin Obstet Gynaecol, 2008, 22(15):763-774.
|
[4] |
Say L, Souza JP, Pattinson RC, et al. Maternal near-miss: Towards a standard tool for monitoring quality of maternal health care. Best Pract Res Clin Obstet Gynaecol 2009, 23(3):287-296.
|
[5] |
Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: Major obstetric hemorrhage in Scotland, 2003-2005. BJOG, 2007, 114(11):1388-1396.
|
[6] |
Joseph KS, Rouleau J, Kramer MS, et al. Investigation of an increase in postpartum haemorhage in Canada. BJOG, 2007, 114(6):751-759.
|
[7] |
Gray C. Long before Krever′s report, blood scare had changed face of medicine. CMAJ, 1998,158(1):89-91.
|
[8] |
Confidential Enquiry into Maternal and Child Health. Why mothers die 2000-2002: The sixth report of the confidential enquiries into maternal deaths in the United Kingdom, London: RCOG Press, 2004.
|
[9] |
Rorberts CL, Cameron CA, Bell JC, et al. Measuring maternal morbidity in routinely collected health data: Development and validation of a maternal morbidity outcome indicator. Med Care, 2008, 46(8):786-794.
|
[10] |
Pattinson R, Say L, Souza JP, et al. WHO maternal death and near-miss classifications. Bull World Health Organ, 2009, 87(10):734.
|
[11] |
Rorberts CL, Ford JB, Algert CS, et al. Trends in adverse maternal outcomes during childbirth: A population-based study of severe maternal morbidity. BMC Pregnancy Childbirth, 2009,9:7.
|
[12] |
Liu S, Joseph KS, Bartholomew S, et al. Temporal trends and regional variations in severe maternal morbidity in Canada, 2003 to 2007. J Obstet Gynaecol Can, 2010,32(9):845-853.
|
[13] |
Zhang WH, Alexander S, Bouview-Colle MH, et al. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: The MOMS-B survey. BJOG, 2005,112(1):89-96.
|
[14] |
Brace V, Penney G, Hall M. Quantifying severe maternal morbidity: A Scottish population study. BJOG, 2004,111(5):481-484.
|
[15] |
Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003. Am J Obstet Gynecol,2008, 199(2):133.
|
[16] |
Public Health Agency of Canada. Canadian Perinatal Health Report, 2008 Edition. Ottawa: Ministry of Public Works and Government Services Canada,2008.
|
[17] |
Cameron CA, Roberts CL, Olive EC, et al. Trends in postpartum haemorrhage. Aust N Z J Public Health, 2006, 30(2):151-156.
|
[18] |
Ford JB, Roberts CL, Simpson JM, et al. Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet, 2007, 98(3):237-243.
|
[19] |
Haynes K, Stone C, King J. Major morbidities associated with childbirth in Victoria: Obstetric haemorhage and associated hysterectomy. Melbourne: Public Health Group, Department of Human Services,2004.
|
[20] |
Knight M, Callaghan WM, Berg C, et al. Trends in post-partum haemorrhage in high resource countries: A review and recommendations from the International Postpartum Haemorrhage Collaborative Group. BMC Pregnancy Childbirth, 2009,9:55.
|
[21] |
Lewis G (ed). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers′ Lives: reviewing maternal deaths to make motherhood safer 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007.
|
[22] |
Wen SW, Huang L, Liston R, et al. Severe maternal morbidity in Canada, 1991-2001. CMAJ, 2005,173(7):759-764.
|
[23] |
Steegers EA, von Dadelszen P, Duvekot JJ, et al. Preeclampsia. Lancet, 2010, 376(9741):631-644.
|
[24] |
Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension, 2008, 51(4):970-975.
|
[25] |
Haig D. Genetic conflicts in human pregnancy. Q Rev Biol, 1993, 68(4):495-532.
|
[26] |
Moore LE. Recurrent risk of adverse pregnancy outcome. Obstet Gynecol Clin North Am, 2008, 35(3);459-471.
|
[27] |
Skjaerven R, Vatten LJ, Wilcox AJ,et al. Recurrence of pre-eclampsia across generations exploring fetal and maternal genetic components in a population based cohort. BMJ, 2005, 331(7521):877.
|
[28] |
England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci, 2007,12:2471-2483.
|
[29] |
Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ, 2007, 335(7627):974.
|
[30] |
Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol, 1995, 172(4pt 1):1158-1167.
|
[31] |
Kramer MS, Rouleau J, Baskett TF, et al. Amniotic-fluid embolism and medical induction of labour: A respective, population-based cohort study. Lancet, 2006,368(9545):1444-1448.
|